These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30851232)

  • 1. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.
    Vicent S; Lieshout R; Saborowski A; Verstegen MMA; Raggi C; Recalcati S; Invernizzi P; van der Laan LJW; Alvaro D; Calvisi DF; Cardinale V
    Liver Int; 2019 May; 39 Suppl 1():79-97. PubMed ID: 30851232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
    Raggi C; Invernizzi P; Andersen JB
    J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
    Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
    J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of Cholangiocarcinoma Immune Biology.
    Vita F; Olaizola I; Amato F; Rae C; Marco S; Banales JM; Braconi C
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
    Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review.
    Elvevi A; Laffusa A; Gallo C; Invernizzi P; Massironi S
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.
    Kongpetch S; Jusakul A; Ong CK; Lim WK; Rozen SG; Tan P; Teh BT
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):233-44. PubMed ID: 25966424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
    Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
    Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma.
    Wei M; Lü L; Lin P; Chen Z; Quan Z; Tang Z
    Cancer Lett; 2016 Sep; 379(2):253-61. PubMed ID: 26940139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the embryonic protein SOX2 in cholangiocarcinoma.
    Sun Q; Li J; Wang G; Xie Y
    Cell Biochem Biophys; 2014 Nov; 70(2):1311-6. PubMed ID: 24906237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
    Banales JM; Cardinale V; Carpino G; Marzioni M; Andersen JB; Invernizzi P; Lind GE; Folseraas T; Forbes SJ; Fouassier L; Geier A; Calvisi DF; Mertens JC; Trauner M; Benedetti A; Maroni L; Vaquero J; Macias RI; Raggi C; Perugorria MJ; Gaudio E; Boberg KM; Marin JJ; Alvaro D
    Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):261-80. PubMed ID: 27095655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO31 sensitizes cancer stem cells-like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma.
    Zhu Z; Zheng Y; He H; Yang L; Yang J; Li M; Dai W; Huang H
    Liver Int; 2022 Dec; 42(12):2871-2888. PubMed ID: 36269678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
    Braconi C; Roessler S; Kruk B; Lammert F; Krawczyk M; Andersen JB
    Liver Int; 2019 May; 39 Suppl 1():32-42. PubMed ID: 30829432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of intrahepatic cholangiocarcinoma.
    Andersen JB
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):101-13. PubMed ID: 25174625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic classification of cholangiocarcinoma: New concepts.
    Nakanuma Y; Kakuda Y
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
    Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N
    Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
    Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
    Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.